๐Ÿ“Š This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ProtaGene

1.1 - Company Overview

ProtaGene Logo

ProtaGene

Headquarter: Germany
Founded: 20XX๐Ÿ”’
Employees: 100-500๐Ÿ”’
๐ŸŒ Website

Company description

  • Provider of precision medicine solutions supporting drug development, treatment strategies, and patient management, with expertise in immuno-profiling and discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology, leveraging SeroTagยฎ technology to identify biomarkers.

Products and services

๐Ÿ”’

Key contacts

๐Ÿ”’
๐Ÿ”’

Financial details

๐Ÿ”’

1.2 - Competitors and similar companies to ProtaGene

Avalo Therapeutics Logo

Avalo Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies developing monoclonal antibodies and a fusion protein for inflammatory diseases, including AVTX-009 (anti-IL-1ฮฒ), quisovalimab (anti-LIGHT), AVTX-008 (BTLA agonist fusion protein), and AVTX-002 (fully human anti-LIGHT, in Phase 2 for non-eosinophilic asthma, inflammatory bowel diseases, and COVID-19 acute respiratory distress syndrome).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Avalo Therapeutics company profile โ†’
Allergopharma Logo

Allergopharma

HQ: Germany Website
  • Description: Provider of allergen-specific immunotherapy for type 1 allergies such as hay fever and allergic asthma, offering Allergen Immunotherapy (AIT) to induce immunological tolerance, reduce symptoms, and prevent the progression of allergic diseases, along with diagnostics for IgE-mediated allergies to identify triggers for targeted treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Allergopharma company profile โ†’
Abintus Bio Logo

Abintus Bio

HQ: United States Website
  • Description: Provider of in vivo immune cell reprogramming solutions, offering programs for highly selective gene expression targetingโ€”using synthetic biology to target specific cell types or states across gene delivery systemsโ€”for applications in leukemia, solid tumors, autoimmune, infectious, and genetic diseases, and simultaneous engineering of innate and adaptive immune cells for lymphoma and solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Abintus Bio company profile โ†’
Granite Bio Logo

Granite Bio

HQ: Switzerland Website
  • Description: Provider of novel antibody-based biotechnology to treat inflammatory, autoimmune, and fibrotic disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Granite Bio company profile โ†’
Sionna Therapeutics Logo

Sionna Therapeutics

HQ: United States Website
  • Description: Provider of small molecule therapies for cystic fibrosis, including SION-638, an NBD1 stabilizer in Phase 1 clinical trials designed to restore CFTR function; SION-109, a small molecule targeting the ICL4โ€“NBD1 interface, in Phase 1; and SION-719, a second series NBD1 stabilizer in preclinical development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Sionna Therapeutics company profile โ†’
๐Ÿ”’

2.M&A buyers

2.1 Potential strategic acquirers in the sector

๐Ÿ”’
๐Ÿ”’
๐Ÿ”’
๐Ÿ”’ View all strategic buyers with complete profiles
Start Free Trial โ†’

2.2 - Strategic buyer groups for ProtaGene

๐Ÿ”’

Buyer group 1: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”’

Buyer group 2: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”’

Buyer group 3: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial โ†’

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ProtaGene

2.2 - Growth funds investing in similar companies to ProtaGene

๐Ÿ”’ View all growth equity funds with complete profiles
Start Free Trial โ†’

4 - Top valuation comps for ProtaGene

4.2 - Public trading comparable groups for ProtaGene

๐Ÿ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial โ†’

4.3 - M&A Transactions similar to ProtaGene

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
๐Ÿ”’ View all M&A transactions with complete deal terms
Request Free Trial Now โ†’

Frequently Asked Questions

About ProtaGene

What does ProtaGene do?

ProtaGene is a provider of precision medicine solutions supporting drug development, treatment strategies, and patient management, with expertise in immuno-profiling and discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology, leveraging SeroTagยฎ technology to identify biomarkers.

Who are ProtaGene's competitors?

ProtaGene's competitors and similar companies include Avalo Therapeutics, Allergopharma, Abintus Bio, Granite Bio, and Sionna Therapeutics.

Where is ProtaGene headquartered?

ProtaGene is headquartered in Germany.

How many employees does ProtaGene have?

ProtaGene has 1,000 employees ๐Ÿ”’.

When was ProtaGene founded?

ProtaGene was founded in 2010 ๐Ÿ”’.

What sector and industry vertical is ProtaGene in?

ProtaGene is in the Enterprise Software ๐Ÿ”’ sector and industry

M&A Buyers & Acquirers for ProtaGene

Who are the top strategic acquirers in ProtaGene's sector and industry

Top strategic M&A buyers and acquirers in ProtaGene's sector include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Which M&A buyer groups are most relevant for ProtaGene?

Top strategic M&A buyers groups and sectors for ProtaGene include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ , โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Financial Investors investing in ProtaGene's sector and industry vertical

Which are the top PE firms investing in ProtaGene's sector and industry vertical?

Top PE firms investing in ProtaGene's sector and industry vertical include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Who are the top buyout funds acquiring in ProtaGene's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ProtaGene's sector and industry vertical include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Who are the top growth equity funds investing in companies in ProtaGene's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ProtaGene include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Valuation benchmarks of companies in ProtaGene's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ProtaGene?

The key public trading comparables and valuation benchmarks for ProtaGene include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Which are the key trading comparable groups for ProtaGene for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ProtaGene with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ProtaGene's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ProtaGene with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ProtaGene's' sector and industry vertical?

Access recent funding rounds and capital raises in ProtaGene's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ProtaGene